Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Intervenn Biosciences makes Malaysia regional hub

Intervenn Biosciences makes Malaysia regional hub
Share on FacebookShare on Twitter

InterVenn Biosciences, a US-based clinical technology company, has established Malaysia as the regional hub for delivery of its medical healthcare services and products in the ASEAN and Asia-Pacific regions.

The top-prized winner of the prestigious CIO Review APAC Top Artificial Intelligence Company Award 2022, InterVenn Biosciences’ key services and products are involved in research and development and revolutionising the fight against cancers and diseases through the deployment of emerging technologies such as Artificial Intelligence (AI), spectrometry and Machine Learning algorithms to help cancer patients, doctors, scientists and healthcare community.

Preparing Malaysia to be the regional hub, InterVenn Biosciences has secured a new 13,000 sq. ft office and laboratory at Technology Park Malaysia, Kuala Lumpur. The laboratory, outfitted with state-of-art equipment, is the only other InterVenn laboratory outside of the US. This facility provides an opportunity to tap into and grow the locally based, biomedical talent in Malaysia

Aldo Carrascoso

InterVenn CEO and co-founder, Aldo Carrascoso said in a recent statement, the key decisions in selecting Malaysia also lies in his vision to be closer with the patients and experts in the region to accelerate the mission that no one should ever be blindsided by the disease.

“Here at InterVenn, maladies are holistically understood, adequately controlled and even manipulated to benefit all.

“We exist today to revisit the health-disease spectrum with an unprecedented and exclusive focus on “glyco” while incorporating the latest technological advancements and fully supporting our Malaysian office with those tools,” shared Carrascoso.

Meanwhile, Fadzhairi Jabar, InterVenn Malaysia’s General Manager, said a part of this growth was a result of the support of regional collaborators and partners as well as recognition given by the relevant government agency and research institutions.

“InterVenn was certified as part of Bioeconomy Corporation’s BBA programme last year, expanding and fostering this interaction as aligned with our vision towards creating a world where everyone in the region benefits from our goal,” said Fadzhairi.

Utilising Artificial Intelligence (AI), InterVenn Biosciences has developed a first-of-its-kind glycoproteomics-based liquid biopsy solution to detect and diagnose cancers. Its AI-enabled mass spectrometry glycoproteomics platform enables researchers at academic centers and biopharmaceutical companies to assess post-translational modifications at an unprecedented scale and speed.

InterVenn Biosciences has a wide range of breakthrough tests for various types of cancers and diseases in the pipeline. InterVenn’s non-traditional approach to epi-proteomics is a marriage of mass spectrometry and Artificial Intelligence / Machine Learning (AI/ML).

Apart from its Malaysian expansion, InterVenn Biosciences also recently spread its wings in San Diego, South California. – The Health

Tags: InterVenn BiosciencesLocal NewsMedical and healthcare technologiesThe Health 2022The Health OctThe Health Oct 2022theHealth
Previous Post

IJN and Novartis tackle heart disease

Next Post

Promoting children’s health and safety

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Emeritus Professor titles for top academics
    June 29, 2022
    RECOGNISED for their exemplary academic achievements, medical physicist Prof Dr […]
  • Hoping for a better year
    November 29, 2021
    While 2021 has turned out to be worse than expected, there is cautious optimism […]
  • Tengku Puteri Iman receives honorary degree
    January 3, 2023
    Tengku Puteri Raja Tengku Puteri Iman Afzan Al-Sultan Abdullah, the Yang […]
  • Supporting public healthcare system
    November 29, 2021
    Datuk Dr Kuljit Singh President, Association of Private Hospitals Malaysia THE […]
  • Steadfast in its determination
    December 19, 2022
    Duopharma Biotech leads the way to maintain its position as the leading halal […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist